Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT07391410
Conditions
Bone Metastases
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Bone Metastases
Study ID
NCT07391410
Start date
Jan 13, 2026
Status verified date
Aug, 2026
Completion date
Jan, 2031
Anticipated
Primary completion date
Jan, 2031
Anticipated
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Enrollment
500 participants
Anticipated
Arms
Bone Metastases
Primary outcome measure
Central contacts
Carol Morris, MD
212-639-7611Locations
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Recruiting
Basking Ridge, New Jersey, United States, 07920
Contacts
Jonathan Forsberg, MD, PhD
212-639-2076Memorial Sloan Kettering Monmouth (All Protocol Activities)
Recruiting
Middletown, New Jersey, United States, 07748
Contacts
Jonathan Forsberg, MD, PhD
212-639-2076Memorial Sloan Kettering Bergen (All Protocol Activities)
Recruiting
Montvale, New Jersey, United States, 07645
Contacts
Jonathan Forsberg, MD, PhD
212-639-2076Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Recruiting
Commack, New York, United States, 11725
Contacts
Jonathan Forsberg, MD, PhD
212-639-2076Memorial Sloan Kettering Westchester (All Protocol Activities)
Recruiting
Harrison, New York, United States, 10604
Contacts
Jonathan Forsberg, MD, PhD
212-639-2076Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Recruiting
New York, New York, United States, 10065
Contacts
Jonathan Forsberg, MD, PhD
212-639-2076Principal Investigator:
Jonathan Forsberg, MD, PhD
Memorial Sloan Kettering Nassau (All Protocol Activities)
Recruiting
Uniondale, New York, United States, 11553
Contacts
Jonathan Forsberg, MD, PhD
212-639-2076Sponsor
Memorial Sloan Kettering Cancer Center
Last update posted
Aug 20, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2026-08-20.